Background It is well established that screening is effective in reducing the incidence and mortality associated with colorectal cancer (CRC). National screening programs have been implemented in many countries; however, uptake remains an issue. Understanding patient preferences may assist in shaping screening programs and tailoring information about screening tests. Objective Our objective was to undertake a systematic review of discrete choice experiments (DCEs) of CRC screening. Methods A systematic review of DCEs of CRC screening was undertaken in an average-risk general population. The methodological qualities of the studies were assessed using a standard checklist outlining best practice for conjoint studies. Results Nine studies met the selection criteria. Metaanalysis was not possible due to the heterogeneity of the data and methods. However, in eight studies, attributes describing accuracy and/or clinical effectiveness were reported to be statistically significant. We also found that individuals were willing to trade-off other attributes such as an increased risk of complications to gain greater clinical benefits. Screening was also preferred to nonscreening by the majority of respondents, regardless of the test used. Conclusions Understanding and incorporating individuals' preferences in decision making is increasingly considered essential in the health field. Data from DCEs can provide valuable insights into the trade-offs individuals are willing to undertake in respect to CRC screening. Such insights can be used by decision makers to identify screening tests that could maximize informed uptake. It is likely that, with better reporting and evolving methodology, the contribution that DCEs can make to such debates will increase.
Introduction
Colorectal cancer (CRC) is a leading cause of cancerrelated deaths worldwide, accounting for over 10 % of all deaths from invasive cancers, and is second only to cancer of the lung [1] . Randomized controlled trials have shown that early detection through screening is effective in reducing CRC mortality by 15-30 % compared with no screening [2] [3] [4] . Fecal occult blood testing (FOBT) is the most widely studied screening modality [5] , and is recommended by most published guidelines worldwide [6] . However, emerging evidence has reported that screening with other modalities such as flexible sigmoidoscopy and computed tomography (CT) colonography may be beneficial in further reducing cancer-specific mortality in people at average risk for CRC [9, 10] .
Despite the current evidence and recommendations, screening participation and uptake remains low in many Western countries [7, 11, 12] . It has been suggested that participation and uptake may be influenced by discrepancies in screening policy at the organisational level, such as the location of screening practices, as well as individual patient preferences for the screening test [13] . CRC screening modalities differ with respect to several test characteristics, including accuracy, invasiveness, and complications [14] . In choosing a test, individuals must weigh the perceived benefit of CRC mortality reduction against the perceived harms or downsides such as test burden, over-diagnosis, and complications. Numerous decision aids have been developed to assist in this decision-making process, but they are not always informed by preference information [16] .
Discrete choice experiments (DCEs) provide insight into the ways shared decision-making processes occur. DCEs, sometimes also referred to as conjoint analysis studies, provide a quantitative preference or utility estimation within a set of alternatives to determine the influence that various factors have on test preference, and potentially test uptake. DCEs have been increasingly used within health economics over the last 20 years when the focus is on valuing patient experiences, health outcomes or the trade-off between these factors [17] . This is particularly relevant when a decision needs to be made between multiple technologies, and/or patient management strategies. In this study, we systematically reviewed the published evidence on CRC screening preferences in the averagerisk general population derived from DCEs.
Previous Reviews on Preferences of Patients for Colorectal Cancer (CRC) Screening
Three reviews on this topic have been published [18] [19] [20] . The first of these reviews was published in 2006 and included stated-preference studies of cancer screening [18] . Eight studies were identified, three of which examined the issue of CRC screening using either a conjoint analysis [21, 22] or a contingent valuation [23] method. The second review was published in 2010 and specifically evaluated conjoint analysis studies on CRC screening [19] . The authors undertook a focused review of literature in MED-LINE and Embase from 1990 to 2009. Six conjoint analysis studies were identified, two of which were also included in the earlier review [14, 22] . The authors of this paper provided some qualitative data synthesis as well as providing comment on how DCE findings could be integrated into healthcare policy. Recently Ghanouni et al. [20] published a third review of CRC screening conjoint analysis studies, identifying seven conjoint studies, five of which were included in the 2010 review. The review provided a narrative assessment on methodological considerations using the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) guidelines to assess key features of the studies [24] . This current review includes studies additional to those in the above publications, which have been identified through a systematic review of the literature. It adds to the previous reviews in that it provides a methodological assessment and an analysis of the key findings of the included studies.
Methods
We conducted a systematic review based on the standard methods and reporting in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [25] .
Inclusion and Exclusion Criteria
Studies were included if they were full-text DCEs of available tests for colorectal screening in an average-risk population, published in English. Review articles and studies that only reported methodological outcomes were excluded, along with studies that used simple rating scales to measure attitudes, or utility preference-based quality-oflife assessment tools such as the time trade-off technique. Contingent valuation surveys (willingness to pay [WTP]) were also excluded.
Search Strategies
To identify these studies, we undertook a systematic review of the literature. The MEDLINE, Embase, EconLit, and PreMedline databases were searched from inception to April 2013 using a strategy aimed at identifying studies employing discrete choice methodology in screening populations. Medical Subject Heading (MeSH) terms and text words for screening were used for all databases and combined with methodology terms such as 'stated preference' and 'choice experiment' (available as an online supplementary material). These results were then combined with text and MesH terms around preferences and decision making. Google Scholar was also searched using text words from the searches.
The titles and abstracts of potentially relevant studies were scanned for studies pertaining to colorectal screening and, when identified, the full text publications were retrieved for detailed assessment. The reference lists of the retrieved publications were also searched to identify any additional relevant studies not identified in the search.
Data Extraction
The characteristics of all studies were extracted using a pre-specified list agreed on by the authors. Two authors (SW, AK) independently extracted this information, which included general study characteristics (study location, population, sample size, response rate); choice task design (number of attributes and levels, labelled or generic design, screening procedures included, and inclusion of an opt-out option). Authors' own reports of the most influential and least influential attribute were also extracted, along with the reported percentage of participants who choose no screening. Post hoc analysis of attribute parameter values was not undertaken. Aspects such as experimental design and data analysis were extracted as part of a methodological (quality) assessment. Any disagreements were resolved by discussion. Meta-analysis of the data was not undertaken due to heterogeneity in study designs and methods.
Methodological (Quality) Assessment and Analysis
Assessing the quality of DCEs in healthcare is a relatively recent methodological area. Two checklists currently exist to assess methodological aspects of DCEs [24, 26] . This review used the ISPOR checklist [24] , which consists of ten items: defining the research question, attributes and levels, construction of tasks, experimental design, preference elicitation, instrument design, data collection, statistical analyses, results and conclusions, and study presentation. Each item has a main question and three subquestions, which may also have more than one component. This checklist is not designed to produce a quality score based on study characteristics, but instead is intended as a means to highlight methodological aspects and their reporting. The questions highlight aspects of study design that are considered good research practice, with the aim of helping reviewers focus on methodological considerations that may influence the interpretation of results [24] .
Results

Search Results
Our search identified 776 non-duplicate citations, of which 738 articles were ineligible after title and abstract review (Fig. 1) . The remaining 38 articles were retrieved and reviewed in full-text form, with nine found to be eligible and included in the final analyses. No additional studies were identified via through the reference lists of the 38 articles. Of the 29 articles retrieved in full text but not considered relevant, three were excluded because, although they reported on the application of a DCE in CRC screening, they focused on methodological issues rather than the actual preferences of respondents [27] [28] [29] . In two of these studies [28, 29] , the results of the DCE survey had been published in earlier studies, all of which are included in this review [30, 31] . The study by Howard and Salkeld [32] , while also on methodology, is also included as it was included in the 2010 review [19] . A further 16 of the 38 papers were excluded as they did not report outcomes from DCEs. This included two studies using a contingent valuation approach [23, 33] , along with a paper that used a maximum difference scaling tool to assess patient preferences for CRC screening [34] . The conjoint analysis study by Hawley et al. [35] was also excluded because participants rated only a single test in each scenario rather than making a discrete choice between two or more test options.
Study Characteristics
Of the nine included studies, three were undertaken in Australia [21, 32, 36] , two in the Netherlands [30, 37] , two in Canada and/or the USA [31, 38] , one in France [39] , and another in Denmark [22] (Table 1 ). The number of attributes identified varied between nine [38] and two attributes [37] . All studies included at least one attribute related to the clinical effectiveness/and or diagnostic accuracy of the tests. This was either in relation to health outcomes following the implementation of a screening program (mortality risk reduction) or the accuracy (sensitivity and specificity) of an individual test.
There was also substantial variation regarding the number and type of screening tests included in the DCEs. Five studies, three of which were undertaken in Australia, included only consideration of different FOBTs [21, 22, 32, 36, 39] -reflecting the health policy context of the individual country.
The study by Marshall et al. [31] was the most comprehensive in terms of CRC screening technologies. Choices between screening technologies were also unlabelled in all but one study [37] .
All studies included members of the general population. Four studies included participants who had known experience with screening [30, 32, 36, 37] . In two of these studies, respondents were drawn from areas where a specific CRC screening pilot program was or had been conducted to inform decision making [30, 37] , and in the remaining two studies, participants had previously purchased an FOBT kit. One study also surveyed physician preferences on alternative CRC screening tests [40] -it had the largest sample size of all the studies reviewed (n = 1,588) and was the only study to administer its questionnaire online.
Study Appraisal-Methodological Assessment
Research Question
All studies included information on the research question and the rationale for undertaking a DCE. The quality and the amount of information varied among the studies, with more recent studies providing greater detail. Few studies [22, 32, 36] outlined a testable hypothesis as described in the ISPOR document [24] , but most provided a detailed discussion on the clinical and policy implication of screening for CRC around the evaluation of trade-offs.
Attributes and Levels
Attribute and level choice was well described and supported by best practice, with almost all studies stating that they used a combination of literature and focus groups to select attributes and levels. The method of translating this information into the final list of attributes was less well described. The studies conducted by Marshall et al. [38] and Salkeld et al. [21] were the most comprehensive in detailing how attributes were identified and selected. The methodology employed was also the most developed, both studies utilizing techniques such as literature searching, experts, and qualitative analysis of focus groups to determine the final list. Translation issues have been noted for other valueclarification methods such as decision aids [41] . It is recognised that, while there are accepted methods for eliciting potential attributes, methods for selecting final included attributes from all candidate attributes requires further development and research [42] . This would include investigating the impact of attribute choice on study findings. 
Study Design
The studies varied greatly in terms of the information provided about the construction of tasks, experimental design, and preference elicitation (i.e. the way in which preference questions were framed). In general, the more recent publications had greater detail and had undertaken tasks consistent with best practice. Eight of nine studies used a fractional factorial design; the remaining study employed a partial profile, but the exact method of selecting the choices was unclear [22] . Across the eight studies that used a fractional factorial design, the number of choices ranged from 8 to 18 (including consistency tests), with three studies using blocking to decrease the number of choices presented to each respondent [32, 37, 39] . Pilot testing of the choice sets was undertaken in six studies (all published in 2007 or later). In one study [22] , respondents were asked to rank choices, whereas in the remaining studies it was a binary choice, with six studies also including an opt-out 'no screening' question [21, 22, 30, 31, 37, 38] .
Of the eight studies that used a fractional factorial design, four specified that they considered orthogonality [30, 31, 36, 39] . The more recent studies also specified using an efficient design strategy or reported a d-error [37] . In general, information on the properties of the experimental design, such as efficiency score or d-error, or discussion of correlations among attribute levels, was lacking across studies.
Instrument Design
All of the studies collected demographic and/or socioeconomic information on the respondents. This included characteristics such as age, gender, income, education, and ethnicity. Pilot testing, in those studies that undertook such an activity, was also used by some of the authors to improve instrument design and preference elicitation by ascertaining respondents' understanding of the tasks as well as the perceived level of burden of the survey. This would seem to be good practice as indicated by the ISPOR checklist [24] .
Data Collection
Few studies provided the level of detail as suggested under the ISPOR item on data collection [24] . For example, none explained why a particular mode of delivery was chosen. However, mode of delivery was noted by some authors as a potential limitation to the generalizability of results [39] . It can be seen from Table 1 that response rates were greatest in those studies that employed a face-to-face interview technique or used an online form. In the studies that Actual number not reported in paper, calculated from percentages given administered the survey by mail (six studies), the response rate was higher in subpopulations that had experience with screening technologies. Only one study reported undertaking sample size calculations to determine the number of questionnaires to be distributed to participants [32] in order to detect significance. Marshall et al. [38] also considered sample size and noted a 'target' number of respondents but did not provide the same level of detail as provided by Howard and Salkeld [32] . No authors specifically discussed ethical considerations.
Analytical Methods for Estimation of Preferences
Probit models (random effects or bivariate) and multinominal logit models were the most commonly used methods in the reviewed studies. One study used a mixed logit model [32] ; in another study, the type of regression model employed was unclear [22] . While respondent characteristics were reported in most of the studies, few examined the interaction between choice and respondent characteristics; instead the information was used in a descriptive manner. Six studies conducted sensitivity analyses around respondents who had incomplete questionnaires, failed rationality or consistency tests, or were considered non-traders. In three of these studies it was explicitly stated that the responses were retained in the final analysis, even after sensitivity analysis [31, 32, 38] .
Results, Conclusions, and Study Presentations
The manner in which studies were presented and/or results and conclusions were reported varied in quality. Most studies did include some discussion around the implications of the study findings and positioned the results within the broader evidence on CRC screening. Study limitations were also described. As in some of the other areas, the more recently published studies provided greater detail. This is not unexpected given that the application of DCEs in healthcare is relatively recent and fewer studies would have been published prior to 2001, to enable a contextual overview [17] .
Summary
It is difficult to draw conclusions regarding the methodological quality of the included studies. First, the checklist used in this review [24] was developed with the purpose of guiding research and reporting rather than as a qualityscoring checklist. As yet, a quality-scoring tool of DCEs in health is unavailable. Second is the issue around reporting. Evaluation of research depends on the quality and completeness of reporting [43] . From the methodological assessment exercise undertaken in this review, it is clear that the quality of reporting of DCEs is less than optimal. The checklist item associated with data collection provides an example where few studies reported any information on sample size or mode of administration. Discrete choice methodology has evolved substantially over recent years, and it is anticipated that reporting of methodology will improve, particularly with the publication of reporting checklists [24, 26] and the ability of authors to utilize online appendices to provide greater detail. More studies are also being published exploring methodological issues within DCEs [27, 29, 44] , which will ultimately contribute to understanding what constitutes best practice and conversely what may contribute to bias. This will assist in identifying those studies that are of better quality where greater weight can be given to their findings. Until this occurs, policy makers will need to interpret the evidence in terms of applicability and consistency of results.
Key Findings of Included Studies
There is substantial variation across the nine studies in respect to framing, definition, and scale of attributes and levels. It is therefore not possible to directly compare across studies. Table 2 provides a summary of the key findings as reported by the authors, it does not present the actual attribute parameters in a single table. The heterogeneity in the framing and presentation of attributes across the studies means that this kind of collective presentation of parameters is unlikely to facilitate comparison of attribute parameter values across studies; rather demonstrate further the extent of heterogeneity. Therefore, this makes it difficult to reach a consensus view about the general population's preferred attributes of CRC screening.
However, some attributes were common across the studies, and these are discussed below.
Diagnostic Accuracy and Clinical Effectiveness
All studies considered test accuracy and/or clinical effectiveness, which can be interpreted as the 'benefits' of screening. In five studies, the benefits related to the accuracy (sensitivity/specificity) of an individual test, whereas, in the remaining studies, benefits were described in terms of risk reduction of CRC-related mortality (consistent with a framing of a screening program). Accuracy was found to be statistically significant across all five studies. In the other group of studies, CRC mortality risk reduction was also found to be significant, although this varied depending on the value level of the attribute [37] . In only one study was accuracy/clinical effectiveness not shown to be significant [22] . It has been suggested that this may be a result of methodological limitations within the experimental design [19] . In those studies that included more than one attribute relating to accuracy or clinical effectiveness, sensitivity (the ability to correctly identify disease) was stated by the authors as being preferred to other accuracy attributes.
Screening Interventions
Four studies included alternatives that described a variety of CRC screening techniques, and five considered only FOBT tests (Table 1) . These were either framed in the context of a screening program [14] or as an individual test.
Hol et al. [37] reported that both screened and screening-naive subjects preferred flexible sigmoidoscopy and colonoscopy to FOBT screening. Marshall et al. [38] found that fecal DNA testing, colonoscopy, and virtual colonoscopy (CT colonography) were the most preferred tests. Marshall et al. [31] reported similar results, with respondents preferring newer tests such as virtual colonoscopy. In most studies, FOBT was reported as the least preferred option despite being the test most commonly adopted in national screening programs. This in part reflects the complexity of the policy decision process. Results from patient preference studies are only one piece of evidence; other evidence from cost-effectiveness studies and budget impact analysis are also considered in making such policy decisions [19] .
Of the studies that only considered FOBT, few provided enough detail to permit conclusions about the specific type of FOBT test respondents preferred. However, it could be said that patients preferred an FOBT test with increased accuracy (sensitivity) or that optimized the greatest health benefit.
No Screening (Opt Out)
Six of the studies included an opt-out option [21, 22, 30, 31, 37, 38] , with one additional study specifically evaluating patients' preferences for the status quo [36] . Two studies did not include an opt out option [32, 39] ; in the case of the study by Howard and Salkeld [32] , this is because respondents were already participating in screening and the study was a methodological comparison of framing and not designed to estimate uptake.
In the study by Salkeld et al. [21] , 12 % of respondents (n = 34) chose no screening for each of the choice questions. In the studies by Marshall and colleagues [38] this CRC colorectal cancer was reported as a proportion of responses. Respondents were first asked to choose between two screening tests and then between the preferred screening test and no screening. Both studies found that around 30 % of the time respondents choose no screening. Similarly, Gyrd-Hansen and Sogaard [22] found that 34 % of respondents choose no screening as their preferred option when asked to rank different scenarios. These rates may also be influenced by the population sampled; Salkeld et al. [36] found that when participants had experience with a particular screening test they were more likely to opt for the status quo. van Dam et al. [30, 37] and Hol et al. [30, 37] included both a screening-naïve group and a screening-experienced group. Both studies found that those who had previous experience with CRC screening were more likely to prefer screening over no screening. Whilst it is difficult to compare these findings given the different ways in which they were measured, it would seem that the preference for a number of individuals is not to undertake CRC screening.
Nayaradou et al. [39] did not comment on the reasons for not including an opt-out question. While it is acknowledged that the inclusion of an opt-out question may be inappropriate for many types of research questions, we would argue that, in questions concerning screening, such a question is necessary in order to avoid overestimation of uptake [45] .
Screening Interval
Evidence regarding the importance of the frequency of screening is mixed. In the study by van Dam et al. [30] , participants preferred shorter screening intervals and were willing to give up a 12 % mortality relative risk reduction if the screening interval was shortened from once every 10 years to a 2-yearly screening interval. In contrast, frequency of testing was less influential for respondents in the studies by Marshall et al. [22, 31] and Gyrd-Hansen and Sogaard [22, 31] .
Process
While six studies included attributes regarding what the screening test involved, or whether it required preparation, only one study discussed this in detail [30] . van Dam et al. [30] found that bowel preparation influenced screening preference. These results may be explained by the number of levels used to describe this attribute given respondents place more importance upon attributes with a high number of levels [46] . Two other studies [31, 38] also found patients preferred a less invasive process that avoided the need to handle fecal matter. The studies by Marshall and colleagues [31, 38] were the most explicit in terms of outlining the requirement of each test, and it is possible that, had other studies provided similar descriptions, the results would be more consistent.
Costs
Six studies considered costs within the discrete choice questions; all framed the cost attribute and the available levels slightly differently. This varied from defining out-ofpocket expenses over a lifetime [22] to the costs to the patient for an individual screening test [31, 32, 36, 38, 39] . In two of the six studies [22, 39] , participants had an option to choose no out-of-pocket expenses. In the remaining four studies, patients were required to pay out-of-pocket expenses regardless of the test. Two of these studies presented the model results as WTP [32, 38] , with one comparing between different screening modalities [38] . This study by Marshall et al. found that the most valued test among Canadian respondents was virtual colonoscopy with an estimated WTP of $Can232, whereas US respondents valued fecal DNA testing, with an estimated WTP of $US222.
Trade-Offs Between Attributes
A meta-analysis of model parameter estimates is not possible because of heterogeneity across studies in terms of how attributes were presented and framed, and because of differences in scale. We therefore examined whether combining estimates of trade-offs between attributes was feasible, for example by using the marginal rates of substitution between attributes, to inform an overall estimate of WTP across studies, or of the willingness of respondents to trade between benefits and harms. Two studies specifically reported on the marginal rate of substitution between benefits and harms [30, 32] . Howard and Salkeld [32] found that respondents were willing to accept additional unnecessary colonoscopies for one extra cancer found (or one less cancer missed). van Dam et al. [30] reported that respondents would require an additional relative risk reduction in CRC mortality to compensate for other test attributes such as an increase in complications or pain.
Discussion
There is a relatively sizeable body of literature on the assessment of public preferences for CRC screening using DCEs. Despite this, it is difficult to draw definitive conclusions regarding community preferences for one particular test over another because of heterogeneity in the description and type of attributes included. Generally, the studies suggest that the most preferred test would be sensitive, be short in duration (administration), require no preparation, and have no risk of complications [14, 30, 31, 38] . At present, no such test is universally offered for CRC screening, but newer tests such as fecal DNA and virtual colonoscopy (CT colonography) may become viable options once their clinical effectiveness has been established. However, we do know that the low sensitivity of the guaiac FOBT (gFOBT) test is a serious limitation [39] and one of the reasons that fecal immunochemical testing (FIT) is increasingly being used [47] . These findings are consistent with those of Marshall et al. [40] , who reported that, while patients had distinct preferences for CRC tests, there was no single CRC that was overwhelmingly preferred. However, the importance of test accuracy was noted by both Phillips et al. [18] and Marshall et al. [19] in screening preference. The review by Ghanouni et al. [20] draws no conclusions regarding the relative preference of specific attributes or tests; rather, the focus of the paper is on methodological issues and the associated problems in drawing conclusions regarding CRC preferences.
We would agree that it is somewhat challenging to draw any definitive conclusions regarding the relative preference of specific attributes because of methodological issues such as framing that need to be considered in interpretation of the results. Howard and Salkeld [32] explored the impact of attribute framing on preference. Results indicated that when accuracy (sensitivity) was framed as how many 'more cancers found', individuals were willing to undergo more additional unnecessary diagnostic tests than if the sensitivity was framed as 'fewer cancers missed'. This issue was also noted in the review by Ghanouni et al. [20] , along with a limitation concerning oversimplification of information in DCEs. The suggestion is that, by simplifying information presented in the DCE to aid comprehension, there is a danger that key aspects are withheld from patients, thereby influencing preferences-an attribute cannot be valued in a DCE if it is not included. In a recent study, participants' intention to participate in FOBT screening was measured following provision of information about aims and administration of the FOBT test [16] . Intentions varied depending on the level of information provided; intention to participate in screening was highest when participants had basic information about the test (a self-administered test to detect CRC) and lowest when given more detailed information about stool collection (a test that involves sampling three separate bowel movements within 14 days).
Further research is needed to understand the impact such variations have on attribute choice in DCEs.
Additionally, a criticism of DCEs is that stated preferences do not always match revealed preferences [48] . As such, our results also need to be interpreted within the context of other literature, including studies reporting participation rates. Interestingly, and consistent with the literature on stated preferences, a recent meta-analysis of studies reporting participation rates following CRC screening found that, in those studies (n = 21) comparing screening tests (e.g. FOBT vs. FIT, FOBT vs. flexible sigmoidoscopy), participation was highest for less invasive tests [49] . A second meta-analysis looking at the preferences of screened patients who had undergone either colonoscopy or CT colonography found similar results, with most of the included studies reporting a preference for CT colonography [50] . For policy makers, systematic reviews of one method of preference elicitation may not be as helpful as a review of preference literature applicable to the particular healthcare system and/or policy decision. Further support of this approach is from studies suggesting that ethnic, racial, and/or cultural variations exist in relation to CRC test preference [44] .
Recent literature also suggests that individuals should be offered a choice of CRC tests as a means of improving uptake [51] ; however, choice does not always improve participation [52] . It has been suggested that if informed decision making about screening is the goal then multiple approaches are needed from community-based interventions addressing health attitudes to providing individuals with decision-making tools [53] . While the DCE literature does not include such factors, it can inform this broader debate by acting as a values-clarification tool, helping participants elucidate the characteristics of screening tests that are most important to them, thus aiding in the development of tailored communication strategies to assist in informed decision making regarding CRC screening options.
Conclusions
DCEs of CRC screening vary substantially with respect to the study design and statistical analysis. These variations limit the overall conclusions that can be drawn because of the variability in the decision and policy contexts. Nevertheless, the majority of the studies reported that accuracy or clinical effectiveness was an important attribute, and that respondents were willing to trade other attributes for improvements in accuracy. No single test seemed to be optimal, rather, respondents indicated a preference for a test that was accurate, short in duration, needed no preparation, and had no associated complications. A significant proportion preferred no screening to the currently available screening tests for CRC. Newer tests are beginning to enter the market, with promises of increased effectiveness and fewer complications. As they do, stated preference studies will continue to be important to shape new screening programs or assist with informed consent.
